Health-related quality of life in patients with lung cancer: Validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire

Lung Cancer

Volumn 77, Issue 1, 2012, Pages 205-211

  Arrieta, Óscar ^a   Núñez Valencia, Carolina ^b   Reynoso Erazo, Leonardo ^c   Alvarado, Salvador ^a   Flores Estrada, Diana ^a   Angulo, Laura Patricia ^a   Oñate Ocaña, Luis F ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

EORTC; Lung neoplasm; Mexico; Quality of life; Questionnaires; Validation studies

Indexed keywords

CARBOPLATIN; CISPLATIN; NAVELBINE; PACLITAXEL;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; DISCRIMINANT VALIDITY; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE LUNG CANCER 13; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OVERALL SURVIVAL; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; VALIDATION PROCESS;

AGED; CARCINOMA, BRONCHOGENIC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; LYMPHOCYTE COUNT; MALE; MESOTHELIOMA; MEXICO; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84861743591     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.02.005     Document Type: Article

References (29)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008, cancer incidence and mortality worldwide 2010, International Agency for Research on Cancer, Lyon, France, [IARC CancerBase No. 10]. http://globocan.iarc.fr/.
2. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics 2010. CA Cancer J Clin 2010, 60:277-300.
3. Medina F., Barrera R., Morales J., Echegoyen R., Chavarría J., Rébora F., et al. Primary lung cancer in Mexico city: a report of 1019 cases. Lung Cancer 1996, 14:185-193.
4. D'Addario G., Felip E. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008, 19(Suppl. 2):39-40. ESMO Guidelines Working Group.
5. Sorensen M., Pijls-Johannesma M., Felip E. Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(Suppl. 5):120-125. ESMO Guidelines Working Group.
6. Grutters J., Joore M., Wiegman E., Langendijk J., de Ruysscher D., Botterweck A., et al. Health-related quality of life in patients surviving non-small cell lung cancer. Thorax 2010, 65:903-907.
7. Fayers P.M., Machin D. Quality of life: assessment, analysis and interpretation 2000, Wiley, New York.
8. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:356-376.
9. Bergman B., Aaronson N.K., Ahmezdai S., Kaasa S., Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC core Quality of Life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 1994, 30:635-642.
10. Gronberg B., Bremne R., Flotten O., Amundsen T., Brunsvig P., Hjelde H., et al. Phase III study by the Norwegian Lung Cancer Study Group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 2009, 27:3217-3223.
11. Gebbia V., Lorusso V., Galetta D., Caruso M., Palomba G., Riccardi F., et al. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale. Lung Cancer 2010, 69:218-224.
12. Montazeri A., Milroy R., Hole D., McEwen J., Gillis C.R. Quality of life in lung cancer patients as an important prognostic factor. Lung Cancer 2001, 31:233-240.
13. Langendijk H., Aaronson N.K., De Jong J.M., Ten Velde G.P., Muller M.J., Wouters M. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000, 55:19-25.
14. Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Green F.L., Trotti A. AJCC cancer staging manual 2010, American Joint Committee on Cancer, Springer-Verlag, New York. 7th ed.
15. Oñate-Ocaña LF, Velazquez-Monroy N, Vazquez L, Espinosa-Mireles-de-Villafranca P, Nuñez-Rosas E, Ovando-Ledezma M, et al. Clinical validation of the EORTC QLQ-OG25 questionnaire for the evaluation of health-related quality of life in Mexican patients with esophagogastric cancers. Psychooncology, 2011; in press. doi:10.1002/pon.1974.
16. Koller M., Aaronson N.K., Blazeby J.M., Bottomley A., Dewolf L., Fayers P., et al. Translation procedures for standardised quality of life questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer 2007, 43:1810-1820.
17. Arrarás J.I., Pruja E., Marcos M., Tejedor M., Illarramendi J.J., Vera R., et al. El cuestionario de calidad de vida para cáncer de pulmón de la EORTC QLQ-LC13. Estudio de validación para nuestro país. Oncologia 2000, 23:127-134.
18. Tabachnik B.G., Fidell L.S. Using multivariate statistics 2010, Pearson International, Boston. 5th ed.
19. Fayers P.M., Aaronson N.K., Bjordal K., Groenvold M., Curran D., Bottomley A. The EORTC QLQ-C30 scoring manual 1998, on behalf of the EORTC Quality of Life Group, European, Brussels, Belgium. 3rd ed.
20. Claasens L., Meerbeck J.V., Coens C., Quinten C., Ghislain I., Sloan E.K., et al. Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials. J Clin Oncol 2011, 29:2104-2120.
21. Arrieta O., Cardona A.F., Bramuglia G., Gallo A., Campos-Parra A.D., Serrano S., et al. Genotyping non-small cell lung cancer (NSCLC) in Latin America. J Thorac Oncol 2011, 6:1955-1959.
22. Cheng J., Liu B., Zhang X., Zhang Y., Lin W., Wang R., et al. The validation of the standard Chinese version of European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China. BMC 2011, 11:1-9.
23. Nowak A.K., Stockler M.R., Byrne M. Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J Clin Oncol 2004, 22:3172-3180.
24. Arrieta O., Michel R.M., Villanueva-Rodríguez G., Serna-Thomé G., Flores-Estrada D., Díaz-Romero C., et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small-cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 2010, 10:50. [Abstract].
25. Lissoni P., Brivio F., Fumagalli L., Messina G., Ghezzi V., Frontini L., et al. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors. Int J Biol Markers 2004, 19:135-140.
26. Arrieta O., Saavedra-Pérez D., Kuri R., Avilés-Salas A., Martínez L., Mendoza-Posada D., et al. Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small-cell lung cancer: a prospective analysis. BMC Cancer 2009, 9:119. [Abstract].
27. Maione P., Perrone F., Gallo C., Manzione L., Piantedosi F., Barbera S., et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005, 23:6865-6872.
28. Naughton M.J., Herndon J.E., Shumaker S.A., Miller A.A., Kornblith A.B., Chao D., et al. The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Qual Life Res 2002, 11:235-248.
29. Quinten C., Coens C., Mauer M., Comte S., Sprangers M.A., Cleeland C., et al. Baseline quality of life as a prognostic indicator of survival a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009, 10:865-871.